David M. Lu
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 6
- Lung Cancer Treatments and Mutations 2
- Potassium and Related Disorders 1
- Oncology 4
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Ryon P. Graf (10 shared papers)Ryan Vance Dittamore (9 shared papers)Nicole A. Schreiber (5 shared papers)Howard I. Scher (5 shared papers)Brigit McLaughlin (4 shared papers)Glenn Heller (4 shared papers)Martin Fleisher (4 shared papers)Jessica E. Louw (8 shared papers)
- Journals
- JAMA Oncology (2 papers)BMC Cancer (1 paper)Molecular Cancer Therapeutics (1 paper)Nature Communications (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)
- Partner nations
- United StatesIrelandChina
In The Last Decade
David M. Lu
16 papers receiving 1.4k citations
David M. Lu's Hit Papers
Peers
Comparison fields: 5 of 56
- Cancer Research 388
- Pulmonary and Respiratory Medicine 859
- Oncology 196
- Drug Discovery 1
- Pharmacology 42
Countries citing papers authored by David M. Lu
This map shows the geographic impact of David M. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Lu more than expected).
Fields of papers citing papers by David M. Lu
This network shows the impact of papers produced by David M. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Lu. The network helps show where David M. Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer Hit paper breakdown → | 2016 | 551 |
| 2 | 2018 | 197 | |
| 3 | 2016 | 155 | |
| 4 | 2017 | 112 | |
| 5 | 2016 | 96 | |
| 6 | 2014 | 78 | |
| 7 | 2017 | 67 | |
| 8 | 2019 | 48 | |
| 9 | 2022 | 31 | |
| 10 | 2004 | 25 | |
| 11 | 2011 | 15 | |
| 12 | 2020 | 10 | |
| 13 | 2015 | 9 | |
| 14 | 2008 | 6 | |
| 15 | 2015 | 2 | |
| 16 | 2016 | 1 | |
| 17 | 2016 | 1 |
About David M. Lu
David M. Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pharmacology, Cancer Research and Pathology and Forensic Medicine, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (2 papers), Flavonoids in Medical Research (2 papers), Potassium and Related Disorders (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Cancer Genomics and Diagnostics (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Cancer Research (388 citations), Pulmonary and Respiratory Medicine (859 citations), Oncology (196 citations), Drug Discovery (1 citation) and Pharmacology (42 citations). David M. Lu has collaborated with scholars based in United States, Ireland and China. Frequent co-authors include Ryon P. Graf, Ryan Vance Dittamore, Nicole A. Schreiber, Howard I. Scher, Brigit McLaughlin, Glenn Heller, Martin Fleisher, Jessica E. Louw, Adam Jendrisak and Daniel Costin Danila. Their work appears in journals such as JAMA Oncology, BMC Cancer, Molecular Cancer Therapeutics, Nature Communications and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.